Skip to main content

Table 1 Patient baseline characteristics according to tertiles of stress hyperglycemia ratio

From: Association of stress hyperglycemia ratio and in-hospital mortality in patients with coronary artery disease: insights from a large cohort study

 

Total (n = 8196)

T1 (n = 2732)

T2 (n = 2730)

T3 (n = 2734)

P-value

Age (years)

68 ± 11

69 ± 10

68 ± 11

67 ± 11

<0.001*

Male (n, %)

5266 (64.25%)

1659 (60.72%)

1726 (63.22%)

1881 (68.80%)

<0.001*

BMI (Kg/m2)

25.57 ± 3.41

25.39 ± 3.42

25.57 ± 3.34

25.72 ± 3.45

<0.001*

HR (beats/min)

78 ± 13

77 ± 13

77 ± 13

79 ± 14

<0.001*

SBP (mmHg)

136 ± 19

136 ± 19

136 ± 18

137 ± 20

0.138

DBP (mmHg)

77 ± 12

76 ± 13

77 ± 12

77 ± 12

<0.001*

Smoking (n, %)

3524 (43.00%)

1113 (40.74%)

1163 (42.60%)

1248 (45.65%)

0.001*

Drinking (n, %)

4672 (57.00%)

1466 (53.66%)

1565 (57.33%)

1641 (60.02%)

<0.001*

Hypertension (n, %)

5894 (71.91%)

1992 (72.91%)

1909 (69.93%)

1993 (72.90%)

0.018*

NGR (n, %)

1395 (17.02%)

149 (5.45%)

567 (20.77%)

679 (24.84%)

<0.001*

Pre-DM (n, %)

2389 (29.15%)

842 (30.82%)

1016 (37.22%)

531 (19.42%)

<0.001*

DM (n, %)

4412 (53.83%)

1741 (63.73%)

1147 (42.01%)

1524 (55.74%)

<0.001*

ACS (n, %)

3001 (36.62%)

906 (33.16%)

1004 (36.78%)

1091 (39.90%)

<0.001*

Glucose (mmol/l)

6.55 ± 2.39

5.52 ± 1.30

5.96 ± 1.32

8.17 ± 3.12

<0.001*

HbA1c (%)

6.80 ± 1.38

7.22 ± 1.53

6.46 ± 1.06

6.71 ± 1.40

<0.001*

HDL-C (mg/dL)

1.06 ± 0.27

1.08 ± 0.28

1.07 ± 0.26

1.03 ± 0.27

<0.001*

LDL-C (mg/dL)

2.17 ± 0.83

2.10 ± 0.80

2.21 ± 0.85

2.21 ± 0.83

<0.001*

TC (mg/dL)

3.81 ± 0.98

3.72 ± 0.95

3.85 ± 0.99

3.87 ± 0.99

<0.001*

TG (mg/dL)

1.43 ± 0.94

1.31 ± 0.82

1.44 ± 0.89

1.57 ± 1.07

<0.001*

eGFR (ml/min)

84.68 ± 17.49

82.98 ± 17.88

86.22 ± 16.04

84.84 ± 18.32

<0.001*

Medications

     

Antiplatelets (n, %)

6844 (83.60%)

2284 (83.60%)

2318 (84.91%)

2242 (82.00%)

0.015*

Antihypertensive drugs (n, %)

6200 (76.65%)

2086 (76.35%)

2071 (75.86%)

2043 (74.73%)

0.355

Antilipidemic drugs (n, %)

6901 (84.20%)

2306 (84.41%)

2362 (86.52%)

2233 (81.68%)

<0.001*

  1. * Statistically significant P values